SKAN’s technology and innovation leadership is based on a unique combination of specialist knowledge in the areas of ventilation technology, air conditioning, sterilisation, software programming that must be validated in a pharmaceutically compliant manner, microbiology and chemistry. It is also experienced when it comes to regulatory requirements and production competency.

With its state-of-the-art products and services, SKAN focuses on markets with the highest regulatory requirements in the health sector. These are mainly situated in Europe, North America, Japan, South Korea, and Singapore. In these markets, every third vaccine that is produced in an isolator is filled in a SKAN isolator. SKAN also sells its products in emerging markets such as China, India and Brazil. If the pharmaceutical companies there wish to export to Europe or North America, they also have to fulfill the same strict legal regulations.

« A partnership is not just a business relationship that is all about numbers, facts and efficiency. It is about the people and the trades, all working tirelessly to provide the best possible quality to patients. The people who become long-time friends through such a partnership and find fulfilment in helping others with new technology and the best quality. »

Sebastian Hillbrand, Product Manager SKAN